10x Genomics (NASDAQ:TXG) Given “Overweight” Rating at Stephens
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities researchers at Stephens in a research note issued to investors on Thursday,Benzinga reports. They presently have a $14.00 target price on the stock. Stephens’ price target points to a potential upside of 49.09% from the stock’s current price. A number […]
10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities researchers at Stephens in a research note issued to investors on Thursday,Benzinga reports. They presently have a $14.00 target price on the stock. Stephens’ price target points to a potential upside of 49.09% from the stock’s current price. A number […]
